Evidence map›Paper›PMID 41024302›Full record

ArticleJournal of cannabis research2025

ABCB1 polymorphisms are associated with clinical response to nabiximols in patients with multiple sclerosis-related spasticity.

Alessandra Gemma, Marco Mauri, Paola Banfi, Maurizio Versino, Alen Zollo, Filippo Martinelli Boneschi, Franca Marino, Marco Cosentino, Marco Ferrari

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cannabis research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessandra GemmaCenter for Research in Medical Pharmacology, University of Insubria, Via Monte Generoso n.71, Varese, 21100, Italy.
Marco MauriNeurology and Stroke Unit, ASST Sette Laghi Hospital, Varese, 21100, Italy.
Paola BanfiNeurology and Stroke Unit, ASST Sette Laghi Hospital, Varese, 21100, Italy.
Maurizio VersinoNeurology and Stroke Unit, ASST Sette Laghi Hospital, Varese, 21100, Italy.
Alen ZolloCenter for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
Filippo Martinelli BoneschiCenter for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
Franca MarinoCenter for Research in Medical Pharmacology, University of Insubria, Via Monte Generoso n.71, Varese, 21100, Italy.
Marco CosentinoCenter for Research in Medical Pharmacology, University of Insubria, Via Monte Generoso n.71, Varese, 21100, Italy.
Marco FerrariCenter for Research in Medical Pharmacology, University of Insubria, Via Monte Generoso n.71, Varese, 21100, Italy. marco.ferrari@uninsubria.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ABCB1Multiple sclerosisNabiximolsSingle nucleotide polymorphismsSpasticity

Identifiers

PMID41024302
PMCPMC12482451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.